Despite these many significant concerns, our Republican colleagues would have taxpayers pay monopoly prices for questionable drugs and devices.
We should be increasing our investment in medical research, not slashing it.
While my focus has been principally on drug pricing today, this hearing also, of course, deals with the question of medi...
I am particularly concerned that under what we have termed the 'Republican Default on America' legislation that was appr...
I think that much of the research shows that a good way to get new cures is to invest in the NIH.
I think that patients deserve a system that generates innovative research.
I think paying outrageous drug prices hasn't resulted in innovation. In fact, I think it has had just the opposite effec...
the NIH's budget should be doubled. But shockingly, a bill passed by the House instead cut NIH's funding by $10 billion.
Finally, Mr. Chairman, we have a responsibility to ensure that patients come first and that it is their health and their...
I hope that moving forward we will not once again yield to the power of Big Pharma, instead, move to advance reasonable ...
The real angel investors in research and development for new cures in America are none other than American taxpayers.